Bispecific Antibodies


Creating First in Class Multispecific Antibody Modalities

The bispecific antibodies stream at the PEGS Summit will take you through a review of constructs, to the engineering and platform development all the way to preclinical and clinical data. Newer platforms, innovative approaches and constructs are combining to yield unprecedented efficacy. Don’t miss the most significant forum of the year to hear about new advances in the industry and meet face to face with leaders changing the future of biologics. 

Conferences and Training Seminars Include:

May 15-16

Agenda 3Introduction to Bispecific Antibodies

May 16-17

Agenda 3Advancing Bispecific Antibodies and Combination Therapy to the Clinic

May 18-19

Agenda 3Engineering Bispecific Antibodies

Keynote Presentations:

Triggered Bispecifics
JoAnn A. SuzichJoAnn A. Suzich, PhD, Head, Research, Immunocore LLC

Antibody-Cytokine Fusions for the Treatment of Difficult-to-Cure Cancer Types: Emerging Clinical Results
Dario NeriDario Neri, PhD, CEO and CSO, Philogen

Register Now

View By: